作者
Shijun Ren, Eric J Lien, Nicholas C Turner, John C Clapham, Laszlo Prokai, Ravenska TE Wagey, Charles Krieger, Vera M Kolb, Kirk W Johnson, Lee A Phebus, Marlene L Cohen, Barry A Kenny, Mark Bushfield, David J Parry-Smith, Simon Fogarty, J Mark Treherne, Vera M Kolb
发表日期
1998
来源
Progress in drug research
页码范围
185-217
出版商
Birkhäuser Basel
简介
Selected works are discussed which clearly demonstrate that mimicking various aspects of the process by which natural products evolved is becoming a powerful tool in contemporary drug discovery. Natural products are an established and rich source of drugs. The term “natural product” is often used synonymously with “secondary metabolite.” Knowledge of genetics and molecular evolution helps us understand how biosynthesis of many classes of secondary metabolites evolved. One proposed hypothesis is termed “inventive evolution.” It invokes duplication of genes, and mutation of the gene copies, among other genetic events. The modified duplicate genes, per se or in conjunction with other genetic events, may give rise to new enzymes, which, in turn, may generate new products, some of which may be selected for. Steps of the inventive evolution can be mimicked in several ways for purpose of drug …
引用总数
200020012002200320042005200620072008200920102011201220132014201520162017201820192020211231211221
学术搜索中的文章
S Ren, EJ Lien, NC Turner, JC Clapham, L Prokai… - Progress in drug research, 1998